News
AUSTIN, Texas, March 09, 2023 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq ... following review of its Investigational New Drug Application (“IND”) to proceed for clinical testing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback